Bio-Techne 

€62.26
127
+€0.04+0.06% Friday 19:55

Statistics

Day High
62.36
Day Low
61.96
52W High
63.32
52W Low
36.4
Volume
-
Avg. Volume
-
Mkt Cap
9.7B
P/E Ratio
-
Dividend Yield
1.07%
Dividend
0.67

Upcoming

Dividends

1.07%Dividend Yield
Sep 26
€0.56
Sep 26
€0.07
May 26
€0.07
Feb 26
€0.07
Nov 25
€0.07
10Y Growth
-0.62%
5Y Growth
0.58%
3Y Growth
-3.08%
1Y Growth
-6.28%

Earnings

3NovExpected
Q4 2025
Q1 2026
Q2 2026
Next
0.37
0.4
0.43
0.45
Expected EPS
0.3790334816
Actual EPS
N/A

Financials

6.3%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.11BRevenue
69.75MNet Income

Analyst Ratings

52.45Average Price Target
The highest estimate is 55.39.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TE1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a broad range of products and services similar to Bio-Techne, including life sciences solutions and analytical instruments, making it a direct competitor.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in similar segments as Bio-Techne, including life sciences and diagnostics, offering competitive products and technologies.
Illumina
ILMN
Mkt Cap32.55B
Illumina, Inc. specializes in genomics and DNA sequencing technologies, competing with Bio-Techne's genomic and proteomic product offerings.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies provides comprehensive solutions in life sciences, diagnostics, and applied chemical markets, directly competing with Bio-Techne's analytical and diagnostic products.
Waters
WAT
Mkt Cap40.74B
Waters Corporation offers analytical instruments, software, and services that compete with Bio-Techne's chromatography and mass spectrometry solutions.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories, Inc. provides a wide range of products and services for the life science research and clinical diagnostic markets, making it a competitor in several areas of Bio-Techne's business.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with Bio-Techne's offerings in similar fields.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions that compete with Bio-Techne's analytical instrumentation and reagents.
Repligen
RGEN
Mkt Cap9.95B
Repligen Corporation provides bioprocessing technologies and solutions that support the development and production of biologic drugs, competing with Bio-Techne in the biotechnology and pharmaceutical research sectors.

About

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Show more...
CEO
Kim Kelderman
Employees
3000
Country
United States
ISIN
US09073M1045
WKN
000A12ENG

Listings

0 Comments

Share your thoughts

FAQ

What is Bio-Techne stock price today?
The current price of TE1.STU is €62.26 EUR — it has increased by +0.06% in the past 24 hours. Watch Bio-Techne stock price performance more closely on the chart.
What is Bio-Techne stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Bio-Techne stocks are traded under the ticker TE1.STU.
Is Bio-Techne stock price growing?
TE1.STU stock has fallen by -0.1% compared to the previous week, the month change is a -0.1% fall, over the last year Bio-Techne has showed a +34.76% increase.
What is Bio-Techne market cap?
Today Bio-Techne has the market capitalization of 9.7B
When is the next Bio-Techne earnings date?
Bio-Techne is going to release the next earnings report on November 03, 2026.
What were Bio-Techne earnings last quarter?
TE1.STU earnings for the last quarter are 0.45 EUR per share, whereas the estimation was 0.45 EUR resulting in a +0.12% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Bio-Techne revenue for the last year?
Bio-Techne revenue for the last year amounts to 1.11B EUR.
What is Bio-Techne net income for the last year?
TE1.STU net income for the last year is 69.75M EUR.
Does Bio-Techne pay dividends?
Yes, TE1.STU dividends are paid quarterly. The last dividend per share was 0.07 EUR. As of today, Dividend Yield (FWD)% is 1.07%.
How many employees does Bio-Techne have?
As of September 06, 2026, the company has 3,000 employees.
In which sector is Bio-Techne located?
Bio-Techne operates in the Health & Wellness sector.
When did Bio-Techne complete a stock split?
The last stock split for Bio-Techne was on November 30, 2022 with a ratio of 4:1.
Where is Bio-Techne headquartered?
Bio-Techne is headquartered in MINNEAPOLIS, United States.